Movymia, Injektionslösung

7680668180011 CH-66818 Injektionslösung
Movymia, Injektionslösung
Movymia, Injektionslösung
Movymia, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Stück
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
21/08/2025
Patient information leaflet
Français
21/08/2025
Patient information leaflet
Italien
21/08/2025
Summary of Product Characteristics
Allemand
21/08/2025
Summary of Product Characteristics
Français
21/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
250.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.03 MG Substance HBESI

Reimbursement information

Public price
CHF 278.40
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/09/2019

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
66818
Drug name
Movymia, Injektionslösung
Galenic form
LSINJ
ATC Code
H05AA02
Authorization status
Z
Dispensing category
B
First authorization
17/10/2018
Authorization expiration date
31/12/9999
IT Number
07.99.0.
Domain
Human medicine
Field of application
Postmenopausale Osteoporose bei Frauen; primäre und hypogonadale Osteoporose bei Männern. Glukokortikoid-induzierte Osteoporose bei Erwachsenen mit erhöhtem Frakturrisiko.

Package details

Description (FR)
MOVYMIA sol inj 250 mcg/ml cartouche 2.4 ml
Description (DE)
MOVYMIA Inj Lös 250 mcg/ml Patrone 2.4 ml
Market launch
17/10/2018
Narcotic (BTM)
No

Available generics (1)

Teriparatid-Mepha, Injektionslösung im Fertigpen
GTIN: 7680661020017
CHF 225.60
View

Other package sizes (1)

None
3 STU
GTIN: None
Not in V1